Siegesbeckia glabrescens induces apoptosis with different pathways in human MCF-7 and MDA-MB-231 breast carcinoma cells

Oncology Reports

Volumn 15, Issue 6, 2006, Pages 1461-1467

  Jun, Soo Young ^a   Choi, Yung Hyun ^b   Shin, Heung Mook ^a  

^a Dongguk University   (South Korea)

^b Dong Eui University   (South Korea)

Author keywords

Apoptosis; Bax; Bcl 2; Breast cancer cells; Caspase; Siegesbeckia glabrescens

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; COL11A2 PROTEIN, HUMAN; COLLAGEN TYPE 11; DNA FRAGMENT; ESTROGEN RECEPTOR; HERBACEOUS AGENT; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; ASTERACEAE; BIOSYNTHESIS; BREAST TUMOR; CELL GROWTH; CHEMISTRY; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; ASTERACEAE; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CASPASE 3; CASPASE 8; CASPASE 9; CELL GROWTH PROCESSES; CELL LINE, TUMOR; COLLAGEN TYPE XI; DNA FRAGMENTATION; DRUGS, CHINESE HERBAL; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ESTROGEN; RNA, MESSENGER;

EID: 35648933260     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.6.1461     Document Type: Article

References (32)

1. Lippman ME: Endocrine responsive carcinomas of man. In: Textbook of Endocrinology. Williams RH (ed). WB Saunder Corp., Philadelphia, pp1309-1326, 1985.
2. Jordan VC and Murphy CS: Endocrine pharmacology of antiestrogens as antitumor agents. Endocr Rev 11: 578-610, 1990.
3. Rochefort H, Capony F, Garcia M, Cavailles V, Freiss G, Chambon M, Morisset M and Vignon F: Estrogen-induced lysosomal proteases secreted by breast cancer cells. A role in carcinogenesis? J Cell Biochem 35: 17-29, 1987. (Pubitemid 17167394)
4. Sheikh MS, Garcia M, Pujol P, Fontana JA and Rochefort H: Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers? Invasion Metastasis 14: 329-336, 1995.
5. Wu J: Apoptosis and angiogenesis: two promising tumor markers in breast cancer. Anticancer Res 16: 2233-2240, 1996.
6. Furth PA: Apoptosis and the development of breast cancer. In: Breast Cancer: Molecular Genetics, Pathogenesis, and Therapeutics. Bowcock AM (ed). Humana Press, New Jersey, pp171-180, 1999.
7. Chien ALT and Pihie AHL: Styrylpyrone derivative induces apoptosis through the up-regulation of Bax in the human breast cancer cell line MCF-7. J Biochem Mol Biol 36: 269-274, 2003. (Pubitemid 36896162)
8. Candi E, Melino G, Laurenzi VD, Piacentini M, Guerrieri P, Spinedi A and Richard AK: Tamoxifen and somatostatin affect tumours by inducing apoptosis. Cancer Lett 96: 141-145, 1995.
9. Ameyar M, Azeddine A, Zhenzi C, Stancou R, Shatrov V, Bettaieb A and Salem C: Analysis of human breast adenocarcinoma MCF7 resistance to tumor necrosis factor-induced cell death: J Biol Chem 273: 29002-29008, 1998.
10. Soto-Cerrato V, Liagostera E, Montaner B, George LS and Perez-Tomas R: Mitochondria-mediated apoptosis operating irrespective of multidrug resistance in breast cancer cells by the anticancer agent prodigiosin. Biochem Pharmacol 68: 1345-1352, 2004. (Pubitemid 39179393)
11. Primchanien M, Nuttavut K, Omboon L, Suna J and Narongchai P: Antiproliferative activity of Thai medicinal plant extracts on human breast adenocarcinoma cell line. Fitoterapia 75: 375-377, 2004.
12. Kenji I, Teru H, Makoto H, Noopur R, Shaji K, Hiromasa H, Norihiko S, Hiroshi Y, Aldo MR, Richardson P, Podar K, Gouill SL, Chauhan D, Tamura K, Arbiser J and Anderson KC: Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and independent apoptosis. Blood 106: 1794-1800, 2005. (Pubitemid 41208596)
13. Efferth T, Rose DD, Gebhart E and Neugebauer M: Activity of ascaridol from the anthelmintic herb Chenopodium anthelminticum L. against sensitive and multidrug-resistant tumor cells. Anticancer Res 22: 4221-4224, 2002. (Pubitemid 36134461)
14. Kim HM, Lee JH, Won JH, Park EJ, Chae HJ, Kim HR, Kim CH and Baek SH: Inhibitory effect on immunoglobulin E production in vivo and in vitro by Siegesbeckia glabrescens. Phytother Res 15: 572-576, 2001. (Pubitemid 33021860)
15. Choi YH, Im EO, Suh HS, Jin YE, Lee WH, Yoo YH, Kim KW and Kim ND: Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases. Int J Oncol 18: 979-984, 2001.
16. Dini L, Coppola S, Ruzittu MT and Ghibelli L: Multiple pathways for apoptotic nuclear fragmentation. Exp Cell Res 223: 340-347, 1996. (Pubitemid 26089091)
17. Earnshaw WC, Martins LM and Kaufmann SH: Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Ann Rev Biochem 68: 383-424, 1999. (Pubitemid 29449198)
18. Lai KL and Thomas TYW: Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway in human breast cancer cell line MCF-7. Breast Cancer Res Treat 55: 73-83, 1999.
19. Tudor G, Aguilera A, Halverson DO, Laing ND and Sausville EA: Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-XL protein levels. Cell Death Diff 7: 574-586, 2000. (Pubitemid 30303613)
20. Jordan VC: Selective Estrogen receptor modulation: a personal perspective. Cancer Res 61: 5683-5687, 2001.
21. Geisler J, King N, Anker G, Ornati G, Salle ED, Lonning PE and Dowsett M: In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast carcinoma patients. Clin Cancer Res 4: 2089-2093, 1998. (Pubitemid 28415652)
22. Demers LM: Effects of Fadrozole (CGS 16949A) and letrozole (CGS 20267) on the inhibition of aromatase activity in breast carcinoma patients, Breast Cancer Res Treat 30: 95-102, 1994.
23. Robertson JFR, Come SE, Jones SE, Beex L, Kaufmann M, Makris A, Nortier JWR, Possinger K and Rutqvist LE: Endocrine treatment options for advanced breast cancer - the role of fulvestrant. Eur J Cancer 41: 346-356, 2005. (Pubitemid 40187205)
24. Hostanska K, Nisslein T, Freudenstein J, Reichling J and Saller R: Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis. Breast Cancer Res Treat 84: 151-160, 2004. (Pubitemid 38393365)
25. Yang HL, Chen CS, Chang WH, Lu FJ, Lai YC, Chen CC, Hseu TH, Kuo CT and Hseu YC: Growth inhibition and induction of apoptosis in MCF-7 breast carcinoma cells by Antrodia camphorate. Cancer Lett (In press).
26. Herr I and Debatin KM: Cellular stress response and apoptosis in cancer therapy. Blood 98: 2603-2614, 2001.
27. Gross A, McDonnell JM and Korsmeyer SJ: Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911, 1999. (Pubitemid 29407357)
28. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM and Cai J: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997. (Pubitemid 27097312)
29. Nagata S and Golstein P: The Fas death factor. Science 267: 1449-1456, 1995.
30. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL and Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43, 1995.
31. Adams JM and Cory S: The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326, 1998. (Pubitemid 28406819)
32. Green DR and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998. (Pubitemid 28406816)